EURO-EWING-99-R1

NCT00020566 📎

Regimen

Experimental
VAC consolidation (vincristine, actinomycin-D, cyclophosphamide)
Control
VAI consolidation (vincristine, actinomycin-D, ifosfamide)

Population

Standard-risk localized Ewing sarcoma after VIDE induction with good response / small tumor / complete resection

Key finding

In standard-risk patients, cyclophosphamide consolidation is non-inferior to ifosfamide consolidation with less renal toxicity. Allows de-escalation in good-prognosis Ewing.

Source: PMID 24982464

Timeline

    Guideline citations

    • NCCN BONE (p.33)